-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Protagonist Therapeutics, Inc quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2016 to Q1 2024.
- Protagonist Therapeutics, Inc Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $236K, a 4.84% decline year-over-year.
- Protagonist Therapeutics, Inc annual Depreciation, Depletion and Amortization for 2023 was $977K, a 5.51% decline from 2022.
- Protagonist Therapeutics, Inc annual Depreciation, Depletion and Amortization for 2022 was $1.03M, a 27.2% increase from 2021.
- Protagonist Therapeutics, Inc annual Depreciation, Depletion and Amortization for 2021 was $813K, a 14.2% decline from 2020.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)